ACAB

Atlantic Coastal Acquisition Corp II

A blank-check company, or SPAC, formed in Delaware in 2021 to raise money through an initial public offering with the goal of buying and taking public a private business. It originally set its sights on the mobility sector, but in 2024 it instead merged with Abpro Corporation, a biotech firm developing antibody therapies for cancer and other diseases, and the combined company now runs as Abpro Holdings. A fun twist: a company that started hunting for a ride-sharing or auto startup ended up bringing a drug developer to the stock market instead.

Class A Common Stock — Merged with Abpro Corporation to form Abpro Holdings (ABP) in November 2024; CUSIP changed to 000847103 on November 13, 2024

No proxy statement recorded.